Our system’s recommendation today is to STAY LONG. The previous BUY recommendation was issued on 12/16/2013, 4 days ago, when the stock price was 69.7900. Since then COP has risen by +0.13%.
Glad you did trim the holding. He was better than Les, but did not address PIPE. He should tell BOD and management to take pay cut until the completion of the trial, The management overrun the budget for the trial.
Pershing Gold - 273 million shares o/s, a major stakeholder for him. He is far better off to own SNTI as a permanent investor not trader. I do hope he can speed up the human gold - factor 5a discovery. Human gold is priceless only if in the good hand of Chief Share Appreciation Officer.
Philip Frost owns LTS which provided financing for Harlan in 2009, then they sold all position, not sure if they shorted it from $0.3 to $0.03 on the absence of insider buying. This PIPE thing may start here @ $4, then cover at $2??? It is not a good sign for SP as these flip and flops only care about short term, most likely drive SP down. You will see his tune change ONLY IF they seek the seat of BOD, if nothing happen, you can bet they will not stay here long.
Sentiment: Strong Sell
Expect him and others like Bill Ackerman to change the ownership, BOD and management. Share appreciation is #1 job not mickey mouth talking on red chips!
Then they need to admit they chose the wrong management which was underperformed in many years. Step down and replace them with Long and Sam.
The science has no problem and the issue as indicated by Longforlong, we need Sam or similar one back to sell IPs around the world. Sit in the office drinking coffee and #$%$ shareholders is not the way you can increase SP. Harlan at least did not take any salary as he knew there was no room for this additional "cash burns" for admin part of this co. The intrinsic value of this co is ($1.8/share). The BOD has not bought a single share, are they abandoning this co???
Can any one explain the logic behind this? The result of Cohort 3 was ok, and yet they could not raise money above $4.8/share. Unless another shoe will drop, the incoming financing will mark the worst one in the history. We will see who will participate this after recent 100 to 1 reverse split.
So, the notion here is the trend of SP is down even though the efficacy is UP?????
Due to low dosage and lousy trial, every thing has been late since DMF issue in 2009. You are not expecting this management to perform well.
"and have never seen such shotty financings" the o is i.
well, that is enough said about the full understanding of this financial cancer.
74 million in 2009, and finished at 320 million in 2013
3 million after reverse split in 2013, 100 million in 2017
who in the hell will buy these #$%$?
They are not Sam, and have no capital market experience or the price should be way above $10/share. Pathetic?????????